Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,165.00p on 13-02-2026 at 19:35:09
Change 24.00p 1.12%
Buy 2,161.00p
Sell 2,160.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 6,081.00 at 2,165.00p
Day's Volume: 13,836,859
Last Close: 2,165.00p
Open: 2,170.00p
ISIN: GB00BN7SWP63
Day's Range 2,137.00p - 2,171.00p
52wk Range: 1,242.50p - 2,219.00p
Market Capitalisation: £86.89b
VWAP: 2,165.39131p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 6,081 2,165.00p SI Trade
Negotiated Trade
 17:05:40 - 13-Feb-26
Sell* 9,028 2,165.00p Automatic Execution
 16:35:52 - 13-Feb-26
Sell* 972 2,165.00p Automatic Execution
 16:35:45 - 13-Feb-26
Buy* 2,580 2,165.00p Automatic Execution
 16:35:37 - 13-Feb-26
Buy* 5,160 2,165.00p Automatic Execution
 16:35:30 - 13-Feb-26
Sell* 517 2,165.00p SI Trade
 16:35:29 - 13-Feb-26
Sell* 727 2,165.00p SI Trade
 16:35:29 - 13-Feb-26
Sell* 63 2,165.00p SI Trade
 16:35:29 - 13-Feb-26
Sell* 9,702 2,165.00p SI Trade
 16:35:29 - 13-Feb-26
Sell* 166 2,165.00p SI Trade
 16:35:29 - 13-Feb-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Feb 2026 (Fri) 2,170.00 2,171.00 2,137.00 2,165.00 13,836,859
12th Feb 2026 (Thu) 2,143.00 2,149.00 2,110.00 2,141.00 4,835,448
11th Feb 2026 (Wed) 2,161.00 2,168.00 2,126.00 2,150.00 8,124,944
10th Feb 2026 (Tue) 2,163.00 2,187.00 2,132.00 2,168.00 16,786,766
9th Feb 2026 (Mon) 2,200.00 2,219.00 2,156.00 2,159.00 19,198,914
6th Feb 2026 (Fri) 2,166.00 2,198.00 2,152.00 2,198.00 8,478,262
5th Feb 2026 (Thu) 2,090.00 2,196.00 2,083.00 2,180.00 16,400,217
4th Feb 2026 (Wed) 1,935.50 2,111.00 1,920.00 2,080.00 16,788,662
3rd Feb 2026 (Tue) 1,922.50 1,945.50 1,919.00 1,945.50 6,775,935
2nd Feb 2026 (Mon) 1,882.50 1,927.50 1,875.00 1,925.00 12,846,159
30th Jan 2026 (Fri) 1,836.00 1,876.50 1,823.00 1,876.50 8,924,204
29th Jan 2026 (Thu) 1,812.00 1,859.00 1,811.00 1,852.00 9,993,355
28th Jan 2026 (Wed) 1,842.50 1,851.50 1,810.00 1,817.50 12,027,944
27th Jan 2026 (Tue) 1,834.00 1,865.50 1,832.50 1,862.50 4,702,280
26th Jan 2026 (Mon) 1,802.50 1,833.00 1,795.00 1,828.50 3,634,721
23rd Jan 2026 (Fri) 1,814.00 1,814.00 1,796.00 1,801.00 9,062,710
22nd Jan 2026 (Thu) 1,792.50 1,808.00 1,776.50 1,804.50 4,820,384
21st Jan 2026 (Wed) 1,786.50 1,798.50 1,777.00 1,787.50 6,414,843
20th Jan 2026 (Tue) 1,802.00 1,805.50 1,774.00 1,795.50 7,498,672
19th Jan 2026 (Mon) 1,800.00 1,816.00 1,793.00 1,816.00 5,056,429
16th Jan 2026 (Fri) 1,838.00 1,845.00 1,795.50 1,816.50 14,632,764
15th Jan 2026 (Thu) 1,890.50 1,895.50 1,845.00 1,848.00 4,980,454
14th Jan 2026 (Wed) 1,856.50 1,880.50 1,853.50 1,880.50 6,552,424
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
11th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
11th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
11th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
11th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
10th Feb 2026 7:00 am RNS China CDE accepts Arexvy adults 60+ application
9th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
6th Feb 2026 10:30 am RNS Director/PDMR Shareholding
6th Feb 2026 7:00 am RNS Nucala COPD approved by the European Commission
5th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
4th Feb 2026 7:00 am RNS Final Results
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx

13th Feb 2026 09:51

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%

13th Feb 2026 07:58

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall improves from a weak Christmas period but remains below last year's levels. Read More

UK dividends calendar - next 7 days

12th Feb 2026 17:26

Read More

GSK RSV vaccine Arexvy accepted for review in China for adults over 60

10th Feb 2026 10:17

(Alliance News) - GSK PLC on Tuesday said its respiratory syncytial virus vaccine Arexvy has been accepted for review by China's Center for Drug Evaluation for adults aged 60 and over. Read More

LONDON BROKER RATINGS: Deutsche cuts Unilever; Jefferies cuts Greggs

9th Feb 2026 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,446.35
Change43.91

Login to your account

Forgot Password?

Not Registered